Home > Insider Trading > Filing (0001062993-24-006109)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
842023	Bio-Techne Corp	TECH	Biological Products, (No Disgnostic Substances) (2836)	411427402

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1492695	Roeland Nusse	614 Mckinley Pl Ne Minneapolis MN 55413		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-03-07	10,400	$76.98	43,097	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Options (Right to Buy)	$21.84	2016-10-29	2025-10-28	17,040	17,040	Direct
Common Stock	Stock Options (Right to Buy)	$25.30	2017-10-26	2026-10-27	15,940	15,940	Direct
Common Stock	Stock Options (Right to Buy)	$31.26	2018-10-25	2027-10-26	12,500	12,500	Direct
Common Stock	Stock Options (Right to Buy)	$44.96	2019-10-24	2028-10-25	7,592	7,592	Direct
Common Stock	Stock Options (Right to Buy)	$50.41	2020-10-24	2029-10-24	8,044	8,044	Direct
Common Stock	Stock Options (Right to Buy)	$63.92	2021-10-28	2030-10-29	6,028	6,028	Direct
Common Stock	Stock Options (Right to Buy)	$128.81	2022-10-27	2031-10-28	2,532	2,532	Direct
Common Stock	Stock Options (Right to Buy)	$73.94	2023-10-26	2032-10-27	3,460	3,460	Direct
Common Stock	Stock Options (Right to Buy)	$61.51		2033-10-26	3,937	3,937	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2025-10-28	17,040	17,040	Direct
2026-10-27	15,940	15,940	Direct
2027-10-26	12,500	12,500	Direct
2028-10-25	7,592	7,592	Direct
2029-10-24	8,044	8,044	Direct
2030-10-29	6,028	6,028	Direct
2031-10-28	2,532	2,532	Direct
2032-10-27	3,460	3,460	Direct
2033-10-26	3,937	3,937	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.955 to $77.11, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option vests on the earlier of the one year anniversary of the grant date (10/26/2023) or the date of Bio-Techne's 2024 annual meeting of shareholders.